Daiwa Securities Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-265
| Closed | – | – | 1402 |
|
|
2023
Q3 | $0 | Hold |
265
| – | – | ﹤0.01% | 1361 |
|
|
2023
Q2 | $1K | Hold |
265
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q1 | $1K | Hold |
265
| – | – | ﹤0.01% | 1287 |
|
|
2022
Q4 | $1K | Hold |
265
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q3 | $3K | Hold |
265
| – | – | ﹤0.01% | 1202 |
|
|
2022
Q2 | $3K | Hold |
265
| – | – | ﹤0.01% | 1203 |
|
|
2022
Q1 | $4K | Hold |
265
| – | – | ﹤0.01% | 1197 |
|
|
2021
Q4 | $5K | Hold |
265
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q3 | $6K | Buy |
265
+119
| +82% | +$2.69K | ﹤0.01% | 1167 |
|
|
2021
Q2 | $3K | Hold |
146
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q1 | $4K | Buy |
146
+16
| +12% | +$438 | ﹤0.01% | 1094 |
|
|
2020
Q4 | $4K | Sell |
130
-246
| -65% | -$7.57K | ﹤0.01% | 1074 |
|
|
2020
Q3 | $6K | Hold |
376
| – | – | ﹤0.01% | 1071 |
|
|
2020
Q2 | $5K | Hold |
376
| – | – | ﹤0.01% | 1095 |
|
|
2020
Q1 | $5K | Hold |
376
| – | – | ﹤0.01% | 1095 |
|
|
2019
Q4 | $7K | Buy |
+376
| New | +$7K | ﹤0.01% | 1081 |
|